History | Food allergy in under 19s: assessment and diagnosis | Guidance | NICE

Guidance
Skip Standards and indicators submenu
Quality standards
Our quality standards set out priority areas for quality improvement. They highlight areas with identified variation in current practice.
View our quality standards
How to use our quality standards
The timeline for developing quality standards
Help us develop quality standards
Selecting and prioritising quality standards topics
About quality standards
Indicators
Our indicators measure outcomes that reflect the quality of care, or processes linked by evidence to improved outcomes.
View list of indicators
Learn about the committee that develops indicators
About indicators
Skip Life sciences submenu
Life Sciences
We offer tailored support to industry during product development. Our expertise can help you build the evidence needed to achieve market access.
View life sciences
Get support from NICE
NICE Advice service
Trusted, unrivalled expertise.
Make an enquiry
Contact us to discuss your requirements.
Innovative Licensing and Access Pathway (ILAP)
Streamlining patient access to safe, financially sustainable and innovative medicines.
Learn how we evaluate technologies
Health technology evaluation and topic selection manuals
Updated manuals for methods, processes and topic selection.
Digital health technologies
Accelerating our efforts to deliver innovation to the health and care system.
Evidence standards framework
Using the best available evidence to develop recommendations that guide decisions in health, public health and social care.
Our guidance programmes
Ensuring new technologies are clinically effective and offer economic value.
Register your product
Non-pharmaceutical
NHS Innovation Service is a clear and simple point of entry for health technologies to access support and national evaluation programmes.
Pharmaceutical
UK PharmaScan is a database of new medicines, indications and formulations in the pharmaceutical pipeline.
Find published and proposed evaluations
Diagnostics
Guidance on measurements and tests used to evaluate a patient's condition.
Medical technologies
Guidance on medical technologies put forward to NICE by manufacturers.
Technology appraisals
Guidance on new and existing medicines and treatments in the NHS.
Highly specialised technologies
Guidance on the use of highly specialised medicines and treatments.
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
Skip About submenu
About
NICE helps practitioners and commissioners get the best care to patients, fast, while ensuring value for the taxpayer.
Explore about
Our programmes
Learn about the information we produce.
Guidance
Advice
Quality standards
Indicators
Digital health
Topic selection
Get involved
Understand how decisions are made:
Attend a committee meeting
Comment on draft guidance:
Guidance in consultation
Be part of a guidance committee:
Join a committee
Help develop our products:
Register as a stakeholder
Putting you at the heart of our work:
Public involvement
What we do
Social care
Life sciences
NICE international
Patient safety
Shared decision making
View all What we do
Into practice
Social care quick guides
Measuring the use of NICE guidance
Resource planner
View all Into practice
Who we are
The board
The NICE strategy 2021 to 2026
Corporate publications
View all Who we are
- Contact us
- Jobs

History

Stakeholder list updated

Stakeholder list (PDF 128 KB)

Published:

21 September 2018

Surveillance consultation: CG116

Surveillance consultation: CG116
Surveillance review proposal (PDF 391 KB)

Published:

01 August 2018
Stakeholder list (PDF 126 KB)

Published:

01 August 2018
Comments form (MSWord 30 KB)

Published:

01 August 2018

Review documents

Static list review decision (PDF 1.38 MB)

Published:

17 February 2014

Other information

Evidence update (PDF 319 KB)

Published:

01 May 2012

Background information

Remit

Remit (PDF 9.4 KB)

Published:

21 May 2009

Scoping workshop, consultation and final scope

Scoping workshop, consultation and final scope
Final scope (PDF 42 KB)

Published:

28 May 2010
Stakeholder comments on the draft scope (PDF 191 KB)

Published:

03 November 2010
Scope consultation information
Scoping workshop notes (PDF 96 KB)

Published:

19 March 2010
Scope equality impact form (MSWord 72 KB)

Published:

01 September 2010

Guideline development and consultation

Guideline development and consultation
Equalities impact assessment form (recommendations) (PDF 41 KB)

Published:

23 February 2011
Guideline consultation information
Draft full guideline for consultation (PDF 344 KB)

Published:

09 August 2010
Guideline consultation - full guideline appendices
Guideline consultation - full guideline, appendix 1 (PDF 597 KB)

Published:

09 August 2010
Guideline consultation - full guideline, appendix 2 (PDF 206 KB)

Published:

09 August 2010
Guideline consultation - full guideline, appendix 3 (PDF 329 KB)

Published:

09 August 2010
Guideline consultation - confidentiality agreement (MSWord 51 KB)

Published:

09 August 2010
Appendices
Guideline development group membership list (PDF 15 KB)

Published:

19 March 2010
Guideline development group minutes
Minutes of GDG meeting on 23-24 March 2010 (PDF 54 KB)

Published:

03 September 2010
Minutes of GDG meeting on 30 April 2010 (PDF 36 KB)

Published:

03 September 2010
Minutes of GDG meeting on 26 May 2010 (PDF 49 KB)

Published:

03 September 2010
Minutes of GDG meeting on 5-6 July 2010 (PDF 24 KB)

Published:

03 November 2010
Minutes of GDG meeting on 28 September 2010 (PDF 21 KB)

Published:

03 November 2010

Pre-publication check

Pre-publication check information
- error reporting table (PDF 16 KB)

Published:

22 February 2011
Guideline for pre-publication check
Guideline for pre-publication check (PDF 383 KB)

Published:

26 November 2010
Guideline appendices for pre-publication check
Guideline appendix 1 for pre-publication check (PDF 642 KB)

Published:

26 November 2010
Guideline appendix 2 for pre-publication check (PDF 203 KB)

Published:

26 November 2010
Guideline appendix 3 for pre-publication check (PDF 337 KB)

Published:

26 November 2010
Response to stakeholder comments on the draft guideline (PDF 472 KB)

Published:

26 November 2010